WHO ICTRP trial
Phase IV study to evaluate the efficacy and safety of Fang Le Shu compared to…
ChiCTR2600116360 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2600116360 |
|---|---|
| Public title | Phase IV study to evaluate the efficacy and safety of Fang Le Shu compared to Guo Na Fen for controlled ovarian stimulation in infertile women undergoing in vitro fertilization-embryo transfer (IVF-ET). |
| Scientific title | A Phase IV, Prospective, Randomized, Open-label, Active-controlled, Parallel-group, Multicenter Study to Evaluate Efficacy and Safety of Fang Le Shu (recombinant FSH) Versus Guo Na Fen Used for Controlled Ovarian Stimulation in Infertile Women Undergoing In Vitro Fertilization-Embryo Transfer |
| Primary sponsor | The first affiliated hospital of zhengzhou university |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Infertility |
| Interventions | Experimental Group:Subcutaneous injection of Fangleshu;Comparator group:Subcutaneous injection of Gonafine |
| Registration date | Jan 8, 2026 |
| Target size | Experimental Group:124;Comparator group:124 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: